10 January 2020
EMA/533039/2019
Information Management Division
This document provides an overview of the data management and quality assurance activities performed by the European Medicines Agency (hereafter “the Agency”) on information of suspected
adverse reactions and medicinal products reported to and held in EudraVigilance and the XEVMPD.